🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well TPIV100 and sargramostim work in treat...
Status
Unknown
Location
Mayo Clinic in Arizona
Start Date
2020-02-20
Trial ID
NCT04197687
This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2014-02-18
Trial ID
NCT02003209
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This randomized, open-label, two-arm, multi-center, Phase II study will eva...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2012-02-17
Trial ID
NCT01491737
Treatments Being Tested
This phase II trial studies how well pertuzumab, trastuzumab, and paclitaxe...
Status
Completed
Location
City of Hope Medical Center
Start Date
2013-07-17
Trial ID
NCT01730833
This phase II trial studies the immunologic response and side effects of us...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-04-20
Trial ID
NCT04329065
This phase II trial studies how well copper Cu64-DOTA-trastuzumab positron ...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2016-07-15
Trial ID
NCT02827877
Monoclonal antibodies, such as pertuzumab and cetuximab, can block tumor gr...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-10
Trial ID
NCT00551421
This randomized phase I/II trial studies the side effects of vaccine therap...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2014-02-05
Trial ID
NCT01922921
This phase Ib/II trial studies the side effects and best dose of ribociclib...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2022-04-07
Trial ID
NCT05319873